MARS MRI in Revision THA With a Ceramic Femoral Head and Titanium Sleeve

Sponsor
Colorado Joint Replacement (Other)
Overall Status
Recruiting
CT.gov ID
NCT05686915
Collaborator
(none)
55
1
12.3
4.5

Study Details

Study Description

Brief Summary

Revision total hip replacement using a ceramic head utilizes a titanium sleeve which introduced another articulation into the system that may lead to a local soft tissue reaction. The purpose of this study is to determine the frequency, size and types of MRI documented local tissue reactions in individuals doing well after a revision total hip replacement and ceramic bearing surface that utilizes a titanium sleeve.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: MARS MRI
  • Diagnostic Test: Titanium Labs
  • Diagnostic Test: Cobalt Labs
  • Diagnostic Test: Chromium Labs

Detailed Description

Metal-on-metal total hip arthroplasty (THA) were heralded as a solution for two of the most common problems in hip arthroplasty in the last decade, instability and osteolysis. Unfortunately, their failures have led to diminished enthusiasm for this bearing surface. Adverse local tissue reactions (ATLRs) have been well documented as a means of pain and failure in this population. A recent report revealed that the most commonly used bearing surface in total hip arthroplasty, metal-on-polyethylene, may have up to a 28% incidence of MRI abnormalities in asymptomatic hips. Revision THA using a ceramic head utilizes a titanium sleeve which introduced another articulation into the system that may lead to a local soft tissue reaction. The purpose of this study is to determine the frequency, size and types of MRI documented local tissue reactions in asymptomatic individuals after a revision THA and ceramic bearing surface that utilizes a titanium sleeve. To our knowledge, this has not been studied previously and may provide important baseline features of this diagnostic tool with this particular bearing surface. We hypothesize that there will be fluid collections in a small but clinically significant portion of asymptomatic patients.

Study Design

Study Type:
Observational
Anticipated Enrollment :
55 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Metal Artifact Reduction Sequence MRI in Revision Total Hip Arthroplasty With a Ceramic Femoral Head and Titanium Sleeve
Actual Study Start Date :
Dec 22, 2022
Anticipated Primary Completion Date :
Jun 1, 2023
Anticipated Study Completion Date :
Dec 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Revision Total Hip Arthroplasty

Patients who received a revision total hip surgery utilizing a ceramic femoral head with a titanium sleeve

Diagnostic Test: MARS MRI
metal artifact reduction sequence (MARS) MRI to assess for fluid collections, ATLRs or other abnormalities

Diagnostic Test: Titanium Labs
Labs to look at titanium levels in blood

Diagnostic Test: Cobalt Labs
Labs to look at cobalt levels in blood

Diagnostic Test: Chromium Labs
Labs to look at chromium levels in blood

Outcome Measures

Primary Outcome Measures

  1. MARS MRI abnormalities [2 Years Post Revision Total Hip Replacement]

    Local Tissue Reactions or Fluid collections on the MARS MRI Scan

Secondary Outcome Measures

  1. Titanium Lab Value [2 Years Post Revision Total Hip Replacement]

    Titanium levels in blood

  2. Chromium Lab Value [2 Years Post Revision Total Hip Replacement]

    Chromium levels in blood

  3. Cobalt Lab Value [2 Years Post Revision Total Hip Replacement]

    Cobalt levels in blood

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 99 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients who received a revision total hip surgery utilizing a ceramic femoral head with a titanium sleeve

  • Patient whose age ranges from 18-99

  • Patients who are not experiencing groin pain, thigh pain, or pain with ROM of the hip

  • Patients who are at least 2 years after a revision THA

  • Acetabular implant (cup) was placed in the appropriate position

  • Patients with a Harris Hip Score of >90

Exclusion Criteria:
  • Patients who do not meet the above criteria

  • Patients unable to have an MRI (i.e. pacemaker, metal implants or issues with claustrophobia requiring sedation)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Colorado Joint Replacement Denver Colorado United States 80210

Sponsors and Collaborators

  • Colorado Joint Replacement

Investigators

  • Principal Investigator: Jason M Jennings, MD, Colorado Joint Replacement

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Jason Jennings, Orthopedic Surgeon, Colorado Joint Replacement
ClinicalTrials.gov Identifier:
NCT05686915
Other Study ID Numbers:
  • 1969400
First Posted:
Jan 17, 2023
Last Update Posted:
Jan 17, 2023
Last Verified:
Jan 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Jason Jennings, Orthopedic Surgeon, Colorado Joint Replacement
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 17, 2023